RxDoctor Payments Data

Brian Klostermann, MD

Family Medicine · Highland, ILNPI 1144457169

Payments from drug & device makers

$664in general payments, 2019–2025

Across 32 payments — averaging $20.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$127
  • AbbVie$109
  • Novo Nordisk$86
  • Biosense Webster, Inc.$77
  • Boehringer Ingelheim$76
  • Amgen$59
  • plus $130 from 6 others

What the payments were for

  • Food & beverage$63195%
  • Other$335%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$664 in reported general payments places this provider in the 65th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$472
Medicare patients
35
Services billed
52

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban172$162,829
OzempicSemaglutide90$135,358
JardianceEmpagliflozin74$99,582
TrulicityDulaglutide65$91,458
FarxigaDapagliflozin Propanediol32$34,668
XareltoRivaroxaban32$33,714
MounjaroTirzepatide22$30,890
MyrbetriqMirabegron12$13,802
AbrysvoRsv Vacc, Pref A And Pref B/Pf39$12,310
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog25$10,373
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr19$9,651
Atorvastatin Calcium858$8,509
JanuviaSitagliptin Phosphate16$8,290
TrintellixVortioxetine Hydrobromide11$7,214
Lantus SolostarInsulin Glargine,hum.Rec.Anlog64$6,340

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$86$135,35890 claims
Lilly USA, LLCTrulicity, Mounjaro$127$122,34787 claims
Boehringer IngelheimJardiance$76$99,58274 claims
AbbVieSynthroid$109$2,27931 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Highland

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →